Michael Secora, Angel Investor

"As a scientist and investor, I believe in the increasing inclusion of technology into many aspects of our way of life. As a leader, I choose to serve organizations that have the potential for substantial and long-term positive impact and responsibly choose to shepherd such impact." Michael Secora, PhD, is a scientist, investor, and leader. He is the Chief Corporate Development Officer and Chief Financial Officer of Iambic Therapeutics, a biotech firm that disrupts the therapeutics landscape with its unique AI-driven drug-discovery platform. He was a former Chief Financial Officer and Executive Leader of Value Translation of Recursion, a clinical-stage TechBio company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. His investment portfolio includes Noetik, an AI-native biotechnology company.